chrisvoncsefalvay/vaers-outcomes huggingface dataset:
5 PTS EXPERIENCED FEVER, CHILLS, NAUSEA, VOMITING 48 HRS AFTER IMMUNIZATION.ALLPTS RECEIVED IMMUN FROM SAME VIAL BETWEEN 6-1-89 AND 6-15-89.ONE PT TREATED WITH TYLENOL AND COMPAZINE.
Swelling and warmth over left thigh at the site of injection with no erythema.
When I received my 1st COVID vaccine in Jan, the left side of my face turned red and warm about 25 min. after receiving it. I took advil, and put a cool cloth on it.  (The left side is where the brain blood clot was found in April)  Also, I was quite fatigued after the first vaccine, and had a sore arm for several days.  After the 2nd Moderna vaccine, my entire face and neck got red and warm within 22 min. Enough that I turned the car around and went back to the vaccination location to show them.  They said they thought I was ok to go home, and to phone 911 if I needed to.  When I got home, I again took an advil, like with the first vaccine, and used a cool cloth. Also, had fatigue, and had a sore arm for several days.  I am quite concerned that all my recent health issues could be related to the COVID Moderna vaccines I received, as I have heard that each of them have been somehow related to COVID vaccines.  1. The brain blood clot  (left side of brain).   Severe headache symptoms started on April 8th.   In hospital for 5 days, beginning April 22nd.   Doctor prescribed Pradaxa blood thinner when I went home from hospital.  2. The COVID toes( sores, rash, inflammation)  3. The full body rash, followed by excessive peeling(which was considered the D.R.E.S.S. syndrome from being on Pradaxa blood thinner for the blood clot)   This occurred the last week in May.  I was in the hospital for 3 days.  Took over 4 weeks to recover;  was very ill.  4. The ground glass opacities; respiratory problems with cough.   (discovered in CT scan for kidney)  5. The overall feeling of being ill and fatigued for along time
pt recvd vax 5DEC94 & on 6DEC94 pt presented w/fine red flat lesions on lt extremity pos pruritus; rash gone on 12DEC94;
This spontaneous report was received from a medical assistant regarding multiple unspecified patients of unknown age and gender. The patients' medical history, drug reactions or allergies and concomitant medications were not provided. On unknown dates, the patients were vaccinated with improperly stored LIQUID PEDVAXHIB (dose and route of administration were not provided), Lot # J007097, expiry date 14-MAR-2016. No adverse effects were reported. No additional information was provided. This is one of six reports received from the same reporter. Additional information has been requested.
Same night tried to to to bathroom and couldn't get out of bed. Upper arms and thigh muscles would not work. Weakness lasted for 4 days. Gradually got better. Still a little weak. 5th day arm got really red and itchy. Lasted for a week.
he is having trouble moving and getting up and walking; he is having trouble moving and getting up; he has never had the back pain before with the pain in the muscle; Sick; My husband experienced lower back pain, well today the back pain is really severe; This is a spontaneous report from a contactable consumer. This consumer (patient's Wife) reported for a 64-year-old Male patient (Reporter's husband) that he received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot Number: EW017A and expiry date was not reported, at the age of 64-year-old), via an unspecified route of administration, administered in Arm Left on 25Jun2021 08:00 as dose 1, single for covid-19 immunisation. Medical history included ongoing splenectomy. The concomitant medications were not reported. Patients wife reported that her husband experienced lower back pain well today the back pain is really severe, he is having trouble moving and getting up and walking on 25Jun2021. She states she took him to the ER, and they gave him a muscle relaxer and a pain pill, which didn't help at all. She states they were there for about 4 hours and sent home with some more pain pills and still is not helping; when he left the hospital, he was still in pain. He has never had the back pain before with the pain in the muscle. She states he had no soreness in his left arm. She states she told the ER nurse this as well, but he doesn't have a spleen and she doesn't know if the shot affected him worse because of the immune system to fight it. She remarks her husband is having regrets taking the vaccine because he is so sick. She states the second shot is scheduled for 16Jul2021. Additional Vaccines Administered on Same Date of the Pfizer Suspect were none. Other vaccinations within four weeks prior to the first administration date of the suspect vaccine(s) was none. The patient underwent lab tests and procedures which included urine analysis and x-ray both negative on 26Jun2021. The outcome of event low back pain was recovering and for all the events was unknown.
The child received the Pfizer Vaccine for 5 yrs. - 11 yrs 10mcg/0.2mL and should have received the Pfizer 6 month - 4 yrs 3mcg/0.2mL.
4 vx given after delayed delivery due to inclimate weather; This case was reported by a other health professional via sales rep and described the occurrence of incorrect storage of drug in a patient who received HAV (Havrix pediatric) (batch number 95EJ7, expiry date 6th February 2023) for prophylaxis.   Co-suspect products included hepatitis A vaccine pre-filled syringe device (Havrix Pre-Filled Syringe Device) injection syringe for prophylaxis.   In February 2022, the patient received Havrix pediatric .5 ml and Havrix Pre-Filled Syringe Device. On an unknown date, unknown after receiving Havrix pediatric and Havrix Pre-Filled Syringe Device, the patient experienced incorrect storage of drug. On an unknown date, the outcome of the incorrect storage of drug was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.  Additional details were provided as follows: The age at vaccination was not reported. One to 2 years old patient received dose of Havrix pediatric from a shipment that had delayed delivery due to inclimate weather from 3rd February 2022 till 7th February 2022 but was still showing a good temperature tag alert in the box upon delivery to office.The Glaxosmithkline agreed to return and replace these vaccines on 9th February 2022 due to this longer than normal delivery window even though tag alert was still showing ok after 5 days in transit with this delivery on 7th February 2022. The reporter stated that, on 16th March 2022, learned from the GSK Vaccine Service Center that these 4 Havrix pediatric doses were not returned with rest of claim, and confirmed from the pediatric office on 17th March 2022 that these vaccines were administered to patient around the second week of February. The office was not extremely concerned due to good Glaxosmithkline temperature tag alert upon delivery. No adverse events or patient issues were reported after administration. There seems to be some internal Glaxosmithkline confusion with the temperature tag alerts after 4 days in transit. No evidence given that there was any temperature excursion during delayed delivery to compromise vaccine stability. The reporter consented to follow up. This case was 1 of 4 linked cases, reported by same reporter for different patients.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR049480:Same reporter. US-GLAXOSMITHKLINE-US2022AMR049425:Same reporter. US-GLAXOSMITHKLINE-US2022AMR049401:Same reporter.
NO adverse event.   The patient was vaccinated a first dose with Moderna vaccine  and received second doses Pfizer vaccine instead of Moderna as second dose inadvertently.
Information has been received from a medical assistant concerning an 18 year old male who was vaccinated with a dose of GARDASIL (dose, route, dose and lot number unspecified) by accident instead of a dose of MENACTRA (dose, route, dose and lot number unspecified). The wrong bottle was grabbed. This was a medical error. The patient was not experiencing any known symptoms. No further information is available.
taste and smell is altered/tastes an awful taste; taste and smell is altered; This spontaneous case was reported by a consumer and describes the occurrence of TASTE DISORDER (taste and smell is altered/tastes an awful taste) and PAROSMIA (taste and smell is altered) in a 35-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 069H21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included VITAMIN 15 for an unknown indication.    On 17-Dec-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced TASTE DISORDER (taste and smell is altered/tastes an awful taste) and PAROSMIA (taste and smell is altered). At the time of the report, TASTE DISORDER (taste and smell is altered/tastes an awful taste) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment information was provided.
serious cancers, like breast and liver cancer; serious cancers, like breast and liver cancer; blindness; booster shot; booster shot; This is a spontaneous report from a contactable consumer.  A female patient (reporter's girlfriend) of an unspecified age received the third dose of BNT162B2 (PFIZER COVID-19 VACCINE, lot number: unknown) via an unspecified route of administration on an unspecified date as dose 3 (booster), single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously received the first dose of BNT162B2 (lot number: unknown) and the second dose of BNT162B2 (lot number: unknown), both on an unspecified date at single dose for COVID-19 immunisation. The reporter stated that, the patient got that booster shot. On an unknown date, the reporter stated that the patient was in the hospital right now. The reporter mentioned that the patient health was terrible. The reporter did not want to talk about patient because it was depressing. The reporter mentioned that the patient had blindness and serious cancers, like breast and liver cancer. Outcome of events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
pt recv vax 12NOV96 & pt exp nocturnal lt leg cramping on 14NOV96;the next morning both legs felt sore;pt also reported that lt foot feels numb from time to time;sx were improving;pt past med hx is remarkable for HTN;
Information has been received from a nurse practitioner concerning a female patient who was vaccinated with PNEUMOVAX 23 (no lot number provided).  Subsequently the patient experienced a hot, red, golf ball sized injection site swelling.  The patient recovered on an unspecified date.  The patient sought unspecified medical attention.  No further information is available.
Received SP vaccine 2 weeks ago. 7-8 days after, pt developed a SP pustule on anterior neck, neck lesion scab fell off 04/23/2003
Information has been received from a licensed practical nurse concerning a 10 year old male who in approximately 1997 was vaccinated with a dose of Varivax. On 23-MAR-2006, the patient was seen in the clinic and diagnosed with breakthrough chickenpox. He presented with more than 200 generalized lesions (some vesicular and some already scabbed). The reporter indicated that if possible she would obtain a vesicular fluid sample on 23-MAR-2006 or 27-MAR-2006 for varicella zoster virus identification, and if not, would send a scab. Results of the varicella zoster identification testing were received which indicated that an adequate scab specimen was collected on 23-MAR-2006, was sent to the laboratory on 27-MAR-2006, and was received in the laboratory on 31-MAR-2006. Varicella zoster virus DNA was amplified and the strain identification showed wild-type strain. Additional information has been requested.
This case was reported in a literature article and described the occurrence of pneumonia in a subject of unspecified age and gender born between 1974 and 2008 who was vaccinated with DTPa (small content), (manufacturer unspecified), MMR vaccine (non-gsk) and IPV (non-gsk). Concurrent medical conditions included DiGeorge's syndrome and had a chromosome 22q11.2 microdeletion detected by fluorescence in situ hybridization assay. No further information on the subject's medical, family history or concurrent medication is available. On an unspecified date, the subject received an unspecified dose of DTPa (small content) (administration site and route unknown, batch number not provided), an unspecified dose of MMR vaccine (Non-GSK) (unknown) and an unspecified dose of IPV (Non-GSK) (unknown). 15 days after vaccination with DTPa (small content), MMR vaccine (Non-GSK) and IPV (Non-GSK), the subject experienced pneumonia. This case was assessed as medically serious by GSK. At the time of reporting, the outcome of the event was unspecified. According to the Modified WHO Causality Criteria, pneumonia was unlikely related to vaccination with MMR vaccine. The author's conclusion stated that their data expanded the findings of smaller studies indicating that live vaccination of patients with DGS with mild-to-moderate immunosuppression was well-tolerated. Prospective studies are needed to confirm their findings and offer guidance for live vaccination. Because this study included few patients with DGS with severe immunosuppression, further retrospective investigation of this population is warranted. This case is one of the 18 cases reported in the same literature article.
STUFFY NOSE; COUGH; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 041A21A, and batch number: 041A21A expiry: UNKNOWN) dose was not reported, administered on 05-APR-2021 12:30 to upper left arm for prophylactic vaccination. No concomitant medications were reported. On 05-APR-2021, the subject experienced cough. On 06-APR-2021, the subject experienced stuffy nose. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from cough, and stuffy nose. This report was non-serious.
ED visit and hospital admission for suicidal thoughts, bipolar disorder, major depressive disorder. Behavioral health admission and treatment. Hospital admission within 6 weeks of receiving the COVID vaccine.
hair loss; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A 77-year-old female patient received BNT162b2 (BNT162B2), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: ALOPECIA (non-serious), outcome "unknown", described as "hair loss". Additional information: It was reported that since getting the COVID VACCINES, she was having a lot of hair loss. She confirmed that she has had "every one of them", the Pfizer Covid 19 vaccine.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
a bit achy, sore and achy during the night/left arm still sore; sore all over (joints, muscles, etc); sore all over (joints, muscles, etc); very tired/better but still tired; listless; fever of 100.3; left arm still sore and tender (esp on underside of upper arm)/generally fine but left arm still a bit tender,; bowels a bit different (as if I'd had a fever); This is a spontaneous report from a contactable Consumer. A 74-years-old female patient received second dose of BNT162B2 (solution for injection; (Batch/Lot Number: EN53181) via an unspecified route of administration, administered in left arm on 10Feb2021 at 08:30 as single dose for covid-19 immunisation. Medical history included atrial fibrillation, hypertension and Seasonal allergies. Concomitant medications included apixaban (ELIQUIS), diltiazem. Historical vaccine included BNT162B2 (product 1st Pfizer Covid shot; vaccine date: 20Jan2021; lot number: EL3246; vaccine location: Left arm) for covid-19 immunisation. The patient was not pregnant. Prior to vaccination, the patient was not tested for COVID-19. Since vaccination patient was not tested for covid-19. The patient experienced a bit achy, sore and achy during the night (1st day). On 2nd day she experienced sore all over (joints, muscles, etc), very tired, listless, fever of 100.3. On 3rd day better but still tired, left arm still sore and tender (esp on underside of upper arm). On 4th day generally fine but left arm still a bit tender, bowels a bit different (as if she did had a fever) and treatment was not received for the events. The patient underwent lab tests and procedures which included body temperature fever of 100.3. The outcome of the events was recovered.
they administered approximately 100 doses of expired vaccine; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (they administered approximately 100 doses of expired vaccine) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 049E21A) for COVID-19 vaccination.     No Medical History information was reported.    In November 2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In November 2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (they administered approximately 100 doses of expired vaccine). In November 2021, EXPIRED PRODUCT ADMINISTERED (they administered approximately 100 doses of expired vaccine) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The reporter who was a pharmacist was calling to report that about 100 patients received expired booster Moderna COVID-19 vaccine from 09-Nov-2021 through 21-Nov-2021 with expiry date 11-Oct-2021. Nobody reported side effects. They just discovered the error and reported to VAERS already.  The reporter does not have information on the date the vial was initially stored in the refrigerator and the Date and time vial was first punctured was unknown. The vial was stored in the fridge post puncture and the vial didn't undergo any temperature excursions. Reportedly, the total amount of time the vial was exposed to room temperature range 8° to 25°C= 46° to 77°F was unknown. The vaccines were stored in the freezer and used as soon as they were thawed.  No Concomitant product use was reported. No treatment information was provided.
Patient developed seizure  a few minutes after receiving 1st dose of Moderna, pharmacy called 911, paramedic took pt to the hospital
This spontaneous report as received from a nurse refers to a 19 year old patient of unknown gender. The patient's relevant medical history, concurrent conditions, concomitant medications, drug reactions or allergies were not reported. On 30-AUG-2017, the patient was vaccinated with improperly stored GARDASIL 9 (dosing details were not reported) (lot # N007931, expiry date: 17-NOV-2019) for prophylaxis (incorrect product storage). No adverse effects were reported. Temperature excursion was from 0 degree Celsius (C) to 1 degree C (0.8 degree C) for 52 minutes. The previous temperature excursion was reported as from 9 degree C to 25 degree C (10.9 degree C) for 3 hours 17 minutes. The call was because of a data logger. No product quality complaint involved. This is one of several reports received from the same reporter.; Sender's Comments: US-009507513-1709USA000054:
swelling arm 19x8cm lasted 10 days local rxn complete recovery-mild egg allergy;
a little bit of headache; a little bit of tiredness; got reaction too on vaccination site; This is a spontaneous report from a contactable nurse (patient). A 64-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection), intramuscularly, administered in left arm, on 08Mar2021 (Batch/Lot Number: EN6128; Expiration Date: 30Jun2021) (at the age of 64 years old) as dose 1, single for COVID-19 immunisation. Medical history included reactive high blood pressure; hormone replacement therapy use. Concomitant medication included estradiol taken as hormone replacement therapy. The patient experienced a little bit of headache, a little bit of tiredness, and got a reaction too on vaccination site on an unspecified date in Mar2021. The patient underwent lab tests and procedures on an unspecified date which included a negative COVID test. The patient reported that she has had 12 COVID test and none of them were positive, from Mar2020 until the time of the report, May2021. The patient reported to received azelastine nasal spray and paracetamol (TYLENOL) as treatment for the events. The patient has recovered from the events on an unspecified date in 2021.  No follow-up attempts are possible. No further information is expected.
Patient was given Bivalent COVID injection were the dose was pulled from two vials to make a complete dose
Foster mother brought child in today to report reaction to her influenza vaccination that was given on 2/16/17. She says that on 2/17/17, the school called her, because the child's upper arm was quite swollen (4" in diameter per foster mother) and was red, itchy, and warm to the touch. This lasted 2 days. Foster mother asked if this precludes her from influenza vaccine in the future, and I said a local site reaction did not, per CDC guidelines, preclude from future immunizations.
gases; loose stool/diarrhea; This spontaneous case was reported by a consumer and describes the occurrence of FLATULENCE (gases) and DIARRHOEA (loose stool/diarrhea) in a 57-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In February 2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 30-Oct-2021, the patient experienced FLATULENCE (gases) and DIARRHOEA (loose stool/diarrhea). The patient was treated with LOPERAMIDE HYDROCHLORIDE (IMODIUM) for Adverse event, at an unspecified dose and frequency. At the time of the report, FLATULENCE (gases) and DIARRHOEA (loose stool/diarrhea) outcome was unknown.            Concomitant medications were not provided.
Patient is a 12 yo previously healthy female presenting with optic neuritis. On Friday, 12/23, patient developed a bifrontal headache. Headache went away when she developed black spots in her right eye that started as intermittent but then became always present, and then also affected the left eye. Eye symptoms since progressed to near black out vision - can only see very close in front of her and cannot see color. Went to optometrist for symptoms, sent here due to concern for IIH. Patient has not had any other symptoms such as fever, cough, congestion (though she did have influenza - like illness in early December). No neck pain, back pain, dizziness, ataxia, numbness, tingling, vertigo, vomiting, bowel or bladder dysfunction.    In the ED labs drawn were notable for CRP 1.5, ESR 31. CBC with normal white count 8.1, plt 324, ANC 4,480.  Other labs sent including Labs sent for Hep B (negative), HIV (negative), EBV, CMV, bartonella, treponemal IgG (negative). Started on steroids - symptoms improved mildly but not markedly. MRI concerning for bilateral optic neuritis. LP performed 12/30. IIH noted on LP and MRI. Patient started on PLEX due to minimal improvement with steroids, currently on day 4/5 with some improvement